About this podcast

Dive into the essential science of psychedelics with Dr. Matthew Johnson, a leading researcher in psilocybin. This Huberman Lab Essentials episode explores the therapeutic potential of substances like psilocybin, MDMA, and LSD in treating depression, addiction, and trauma within controlled clinical settings. Discover how these compounds profoundly alter perception and self-identity, offering long-lasting relief, and learn about the science behind microdosing and emerging research on their role in neurological injury recovery. Dr. Johnson breaks down the different classes of psychedelics, their receptor effects, and the critical distinction between various compounds, providing a comprehensive overview for anyone interested in the evolving landscape of psychedelic medicine.